Explore all the latest information in
acute myeloid leukemia
, arranged by key congresses and meetings. Listed below are recently updated congresses and meetings.
Prognostic significance of concomitant gene mutations in intensively treated patients with IDH1/2-mutated AML
At the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation,...
LDAC plus AC220: Results from the LI-1 trial in older patients with AML
During the 25th European Hematology Association (EHA) Annual Congress 2020, Mike Dennis presented an oral abstract on the...
Charles Craddock explains why you should join the virtual AML Hub Satellite Symposium
The AML Hub will hold a virtual satellite symposium at the 46th Annual Meeting of the European Society for Blood...
Adriano Venditti explains how you can get involved with the virtual AML Hub Satellite Symposium
The AML Hub will hold a virtual satellite symposium at the 46th Annual Meeting of the European Society...
What is the optimal gene panel to be assessed for risk stratification?
The AML Hub was pleased to speak to Lars Bullinger, Charité – Universitätsmedizin Berlin, Berlin, DE, during the European School...
How close are we to offering treatment tailored to mutational profile?
During the European School of Haematology (ESH) 2nd How to Diagnose and Treat: Acute Leukaemia meeting, the AML Hub spoke to...
Magrolimab plus azacytidine in patients with myelodysplastic syndromes and acute myeloid leukemia
During the American Society of Clinical Oncology (ASCO) Virtual Meeting 2020, David Sallman from the...
Ivosidenib with venetoclax ± azacitidine in IDH1-mutated myeloid malignancies
Curtis Lachowiez from The University of Texas, MD Anderson Cancer Center, Houston, TX, US, reported an interim analysis at...
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Hematology
European Hematology Association
European School of Haematology
European Society for Blood and Marrow Transplantation
International Symposium on Acute Leukemias
National Cancer Research Institute
NCRI AML Academy 2019
ASTCT and CIBMTR TCT Meeting 2020
EHA–EBMT CAR T Meeting 2020
Society of Hematologic Oncology